Missouri Lawyers Media Missouri legal news and public notices
GlaxoSmithKline, which is paying $3 billion to resolve government claims that it illegally marketed drugs such as the Avandia diabetes medication, agreed to settle more lawsuits over the pills, a lawyer said.
Read More »Home (page 2)
Court: Pfizer must pay $45 million in Prempro cases
Pfizer Inc. must pay more than $45 million in damages to two women who blamed the company’s menopause drugs for their breast cancers, an appeals court ruled.
Read More »Roche ordered to pay ex-Accutane user
Roche Holding AG — ordered by a jury to pay $2 million to a user of its Accutane acne drug who blamed the medicine for bowel disease — persuaded the panel to reject a Hollywood actor’s claims over the medication.
Read More »Pfizer properly warned about Prempro risks, jury finds
Pfizer Inc.’s Wyeth unit properly warned a Virginia woman’s doctors about the risks of its Prempro menopause drug, a jury ruled Friday in rejecting her claim for damages.
Read More »Pfizer wins Ark. woman’s suit over Prempro
Pfizer Inc. properly warned an Arkansas woman about the cancer risks of its Prempro menopause drug, jurors found in rejecting her bid for at least $3.5 million in damages.
Read More »New trial in $31M rollover case
Ford Motor Co. won a new trial in a lawsuit over brain injuries suffered by a teenager in a Bronco II rollover accident that resulted in a $31 million jury award against the U.S. automaker. The South Carolina Supreme Court ...
Tagged with: Ford Motor Co.
Read More »Pfizer wins ruling denying Neurontin class action suit
Pfizer Inc., the world's biggest drugmaker, persuaded a Missouri judge to deny class-action status for a lawsuit alleging the company illegally marketed its Neurontin epilepsy medicine.
Read More »Pfizer wins new trial over menopause drugs
A Pfizer Inc. unit won a re-trial of a Pennsylvania lawsuit over its menopause drugs that ended in a first jury's award of $1.5 million in damages, the company said.
Read More »Goldman Sachs sued over executive compensation plan
Goldman Sachs Group Inc., facing pressure from lawmakers to rein in pay, was sued by a shareholder who contends the bank’s executive compensation plan shortchanges investors. The Goldman Sachs board of directors wasn’t acting in shareholders’ best interests when it ...
Read More »Wyeth, Pfizer deserve $27M penalty over drugs, 8th Circuit told
Wyeth and Pfizer Inc. should pay more than $27 million in punitive damages to an Arkansas woman over the drugmakers’ mishandling of menopause drugs linked to her breast cancer, a lawyer told an appeals court. A federal judge in Arkansas ...
Tagged with: 8th U.S. Circuit Court of Appeals Securities and Exchange Commission Vioxx Wyeth
Read More »
